LYRM3 Peptide

CAT: 0013-GTR18913306Size: 0.05 mgDry Ice: NoHazardous: No

1 / 1

CAT#:0013-GTR18913306Size:0.05 mg

Selected

24/48H Stock Items & 2 to 6 Weeks non Stock Items.

Quick Request Actions

Description

LYRM3 Peptide

Product Name Alternative

B22, LYRM3, CI-B22, UQOR22, Complex I-B22

UniProt

Q9Y6M9

Concentration

200 μg/mL

Form

Liquid

Storage Conditions

Store LYRM3 peptide at -20°C, stable for one year.

Notes

For research use only.

Applications Notes

LYRM3 peptide is used for blocking the activity of LYRM3 antibody.

Tested Applications

Blocking

NCBI Accession Number

Q9Y6M9

Preservative

PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin and 0.02% sodium azide

Related Products

Catalog	Name
GTR18078722	LYRM3 Antibody
GTR18913308	LYRM1 Peptide
GTR18913307	LYRM2 Peptide
GTR18958627	LYRM2 Blocking peptide
GTR18958497	LYRM5 Blocking peptide
GTR19001214	LYRM2 Antibody Blocking Peptide
GTR19050010	Lyrm4 Peptide - middle region
GTR19052417	LYRM1 Peptide - middle region
GTR18979508	LYRM4 Antibody Blocking peptide
GTR19001211	LYRM4 Antibody Blocking Peptide

Catalog	Name
MBS152955-01	LYRM3 Peptide
149401	NDUFB9, Control Peptide (NADH Dehydrogenase [Ubiquinone] 1 beta Subcomplex Subunit 9, Complex I-B22, CI-B22, LYR Motif-containing Protein 3, NADH-ubiquinone Oxidoreductase B22 Subunit, LYRM3, UQOR22)
MBS9402336-01	LYRM3 Antibody
APR08294G	Polyclonal LYRM3 Antibody
A08623-1	Anti-LYRM3 NDUFB9 Antibody
511973	NDUFB9 (LYRM3, UQOR22) discontinued
MBS6428609-01	NDUFB9 (NADH Dehydrogenase [Ubiquinone] 1 beta Subcomplex Subunit 9, B22, LYRM3, CI-B22, UQOR22) (APC)
MBS6428618-01	NDUFB9 (NADH Dehydrogenase [Ubiquinone] 1 beta Subcomplex Subunit 9, B22, LYRM3, CI-B22, UQOR22) (PE)
MBS6428616-01	NDUFB9 (NADH Dehydrogenase [Ubiquinone] 1 beta Subcomplex Subunit 9, B22, LYRM3, CI-B22, UQOR22) (MaxLight 650)
MBS6428615-01	NDUFB9 (NADH Dehydrogenase [Ubiquinone] 1 beta Subcomplex Subunit 9, B22, LYRM3, CI-B22, UQOR22) (MaxLight 550)